Stella Pharma Hits Day Low at JPY 349 Amid Price Pressure

Stella Pharma Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock dropping by 10.95% as of October 14, 2025. The stock reached an intraday low of JPY 349.00, reflecting ongoing challenges in its financial performance.
Over the past day, Stella Pharma's performance starkly contrasts with the Japan Nikkei 225, which saw a modest decline of 1.01%. In the past week, the stock has decreased by 5.79%, while the Nikkei index gained 5.07%. The one-month performance shows a decline of 2.19% for Stella Pharma, compared to a 9.7% increase in the broader market.

Long-term trends indicate a concerning trajectory for Stella Pharma, with a year-to-date decline of 33.33% and a staggering 32.58% drop over the past year. The company's operating profit has seen a dramatic annual decline of 234.76% over the last five years, and it currently reports a negative EBITDA, highlighting its financial difficulties. With a market capitalization of JPY 13,307 million, Stella Pharma continues to face significant hurdles in its operational efficiency and profitability.